Hims & Hers Health Makes Australia, Japan Foray With $1.15 Billion Eucalyptus Acquisition
Synopsis
The company said the acquisition will also deepen its presence in the UK, Germany, and Canada.
Hims & Hers Health, Inc. (HIMS) announced on Thursday that it has signed a definitive agreement to acquire Eucalyptus in a deal valued at up to $1.15 billion.
The transaction, expected to close in mid-2026, will strengthen the company’s ability to deliver personalized digital healthcare internationally, Hims & Hers said.
Upon completion, Hims & Hers plans to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. Eucalyptus CEO Tim Doyle will join Hims & Hers as senior vice president (SVP) of International, and Eucalyptus’ brands will gradually transition to the Hims & Hers platform.
HIMS shares were trading 3.4% higher in premarket on Thursday.
Get updates to this developing story on Stocktwits.<
For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.